chrysene,2-diol-3,4-epoxide-1 has been researched along with Carcinogenesis in 1 studies
*Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balani, SK; Boyd, DR; Chang, RL; Conney, AH; Cui, XX; Huang, MT; Jerina, DM; Lin, Y; Reuhl, KR; Shih, WJ; Wood, AW; Xie, JG; Yagi, H | 1 |
1 other study(ies) available for chrysene,2-diol-3,4-epoxide-1 and Carcinogenesis
| Article | Year |
|---|---|
Mutagenicity and tumorigenicity of the four enantiopure bay-region 3,4-diol-1,2-epoxide isomers of dibenz[a,h]anthracene.
Topics: Animals; Carcinogenesis; Chrysenes; Cricetinae; Epoxy Compounds; Humans; Mice; Mutagenesis; Mutagens; Salmonella typhimurium; Skin Neoplasms; Stereoisomerism; Structure-Activity Relationship | 2013 |